SPHYNKX THERAPEUTICS, LLC

Basic Information

1632 MEADOWBROOK HEIGHTS RD
CHARLOTTESVILLE, VA, 22901-3001

Company Profile

n/a

Additional Details

Field Value
DUNS: 965550804
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Phase II Commercialization of Continuous Countercurrent Tangential Chromatography

    Amount: $316,867.00

    DESCRIPTION: Vascular leak is a hallmark of tissue injury, and results in the movement of plasma into the interstitium where immune mediators and clotting factors invade the injured tissue. Left to p ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Improving in vivo stability of sphingosine kinase inhibitors

    Amount: $152,792.00

    DESCRIPTION (provided by applicant): We and others have hypothesized that inhibiting SphK1 is a powerful therapeutic strategy in pathologies that are characterized by cell hyperproliferation, e.g. can ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government